CLUHP3

Across TCGA pan-cancer cohorts, CLUHP3 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated CLUHP3 data layer compared with 21 for mass-spec protein.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher CLUHP3 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated CLUHP3 expression acts as an unfavorable survival marker, although some lineages such as CCRCC and GBM show a favorable association.

CCRCC and GBM are the cancer types where CLUHP3 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	DFS	Quartile	All	1.000	0.328	.027	12	view →
GBM	DFS	Tertile	All	0.586	0.141	.049	3	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

CLUHP3–CCRCC (DFS)

Open the CCRCC breakdown →